'Pharma bro' Shkreli says he will not testify in securities fraud trial

(Reuters) - Martin Shkreli, the pharmaceutical entrepreneur vilified as the "pharma bro" for raising the price of a life-saving drug by 5,000 percent, said on Monday in federal court that he would not testify in his securities fraud trial.

'Pharma bro' Shkreli says he will not testify in securities fraud trial
Read More


Bagikan Berita Ini